Food effect studies and drug label recommendations: A review of recently approved oncology products.

被引：1
|
作者：
Farha, Mark
Masson, Eric
Tomkinson, Helen
Mugundu, Ganesh
机构：
[1] AstraZeneca, Waltham, MA USA
[2] AstraZeneca, Early Clin Dev, Quantitat Clin Pharmacol, Waltham, MA USA
[3] AstraZeneca, Early Clin Dev, Quantitat Clin Pharmacol, Cambridge, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.2535
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2535
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Food Effect Studies for Oncology Drug Products
    Parsad, S.
    Ratain, M. J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (05) : 606 - 612
  • [2] Evaluation of Pediatric Dosing Recommendations in the Food and Drug Administration (FDA) Approved Labeling of Anti-Infective Products.
    Raheem, Farah
    Voronina, Maria
    Liu, Xiaomei
    Burckart, Gilbert
    Moore, Jason
    PHARMACOTHERAPY, 2018, 38 (04): : E37 - E37
  • [3] EVALUATION AND REPORTING OF IMMUNOGENICITY DATA IN USPI FOR RECENTLY APPROVED THERAPEUTIC BIOLOGIC PRODUCTS.
    Balakrishnan, A.
    Oak, E.
    Wang, J.
    Wang, Y.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 : S37 - S37
  • [4] MAIN MECHANISMS OF PHARMACOKINETIC DRUG-DRUG INTERACTIONS TRIGGERING LABEL RECOMMENDATIONS FOR DRUGS APPROVED BY THE FOOD AND DRUG ADMINISTRATION IN 2018
    Yu, Jingjing
    Petrie, Ichiko
    Ragueneau-Majlessi, Isabelle
    DRUG METABOLISM AND PHARMACOKINETICS, 2020, 35 (01) : S49 - S49
  • [5] Food Effect Study Design With Oral Drugs: Lessons Learned From Recently Approved Drugs in Oncology
    Farha, Mark
    Masson, Eric
    Tomkinson, Helen
    Mugundu, Ganesh
    JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 59 (04): : 463 - 471
  • [6] Prucalopride: A recently approved drug by the food and drug administration for chronic idiopathic constipation
    Mahajan, Rajiv
    INTERNATIONAL JOURNAL OF APPLIED AND BASIC MEDICAL RESEARCH, 2019, 9 (01) : 1 - 2
  • [7] INCONSISTENT LABELING OF FOOD EFFECT FOR ORAL AGENTS WITHIN FDA: DIFFERENCES BETWEEN ONCOLOGY AND NON- ONCOLOGY PRODUCTS.
    Kang, S. P.
    Ratain, M. J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 : S73 - S73
  • [8] REVIEW OF TRANSPORTER INFORMATION IN RECENTLY APPROVED NEW DRUG APPLICATION (NDAs)
    Agarwal, Sheetal
    Zhang, Lei
    Huang, Shiew-Mei
    JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (09): : 1068 - 1068
  • [9] REVIEW OF IN VITRO TRANSPORTER DATA IN RECENTLY APPROVED NEW DRUG APPLICATIONS
    Anathula, H.
    Agarwal, S.
    Zhang, L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 : S91 - S92
  • [10] Demographics of subjects in bioequivalence studies of generic drug products.
    Kim, CY
    Davit, BM
    Conner, DP
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 71 (02) : P19 - P19
12345